Dull business but cracking chart, great dividend and ad hoc takeover rumours. I'm happy to settle for that kind of dull!

Harry :-)

Bought a few earlier @183.5 with an eye on the up coming dividend - currently in auction and I think I'll sell if I can get 20 points.

Out @205p had I bought more, I may have held.

Looks like I should have stayed in - did you buy Harry?

Credit Suisse Neutral 208.50 280.00 220.00 Reiterates

Canaccord Genuity Hold 208.50 400.00 250.00 Downgrades

Investec Hold 208.50 200.00 190.00 Reiterates

Panmure Gordon Sell 208.50 - 200.00 Reiterates

Numis Hold 208.50 - 220.00 Reiterates

Liberum Capital Hold 208.50 - - Reiterates

N+1 Singer Hold 208.50 201.00 201.00 Retains

finnCap Under Review 208.50 - - Under Review

I haven't. I still think this sector is out of favour, particularly as their customers are mostly within the mining industry, which is on it's knees atm. Sub 200p is likely again, imo.

Acquisition of Charter Medical Limited ("Charter")

Fenner is pleased to announce that its wholly owned subsidiary Fenner Drives, Inc. has acquired 100% of the share capital of Charter from its parent company Lydall, Inc. a publicly traded company (NYSE: LDL) headquartered in Connecticut. Charter will be integrated into Solesis Medical Technologies ("Solesis"), part of Fenner's AEP division.

The consideration of US$29.9m was satisfied in cash at completion and the transaction is expected to be earnings enhancing immediately upon acquisition.

Charter manufactures specialty single-use assemblies and Class I and Class II medical devices for the collection, processing, storage and filtration of biological and bioprocessing fluids. Charter also produces bio-containers and fluid management sets that serve a range of life science applications including biopharmaceutical manufacturing, cell therapy and cryogenic storage. Charter is a single site company based in Winston-Salem, North Carolina.

As at 31 December 2014, unaudited gross assets acquired were US$6.9m with underlying EBITDA (1) of US$3.3m for the 12 months to 31 December 2014 on sales of US$19.6m.

The entire workforce of Charter have become employees of Fenner upon completion and will continue to be led by General Manager, Mr. Gael Peron.

Looking better Harry?

Not for me yet, I'm afraid.

Gap closed for now +7.1%.

Pre-Close Trading Statement

StockMarketWire.com
Fenner - a world leader in reinforced polymer technology - posts underlying operating profits of £28.7m for the six months to the end of February, down from £36.6m last time.

Revenues fell to £347.6m from £359.8m and underlying pre-tax profits dropped to £21.8m from £29.6m.

The group posts a pre-tax loss of £5.1m against a profit of £17.6m in 2014.

The interim dividend is maintained at 4.0p per share.

Chief executive Nicholas Hobson said: "The Group's results for the period reflect a good performance by the AEP division and a reduced result from the ECS division which faced challenging market conditions.

"AEP's industrial, medical and other non-oil speciality polymer businesses, which account for some 70 per cent of AEP's revenue, are expected to continue to perform well. The financial results for the second half of the year will also benefit from the acquisition of Charter Medical.

"The remainder of AEP is seeing an impact from lower levels of activity in the oil & gas industry as a result of sharply reduced oil and gas prices. Order intake started to decline in February; the timing and extent of the decline are within the range of our planning assumptions.

"ECS expects to see a continuation of the difficult trading conditions across all of its regions.

"In response to the trading conditions being faced, cash overheads across the Group have been reduced. The Group will continue to closely manage all aspects of its costs and cash flow.

"Taking into account the management actions we are taking in response to the trading conditions, the board's expectations for the outcome for the year remain substantially unchanged overall."

StockMarketWire.com
Fenner has warned that full year earnings, after recognising a lower tax rate, will be slightly below previous management expectations.

It says leading indicators in the mining and energy industries are not yet showing any signs of recovery and the group anticipates the recent challenging market conditions will continue.

It adds: "Nevertheless, we remain encouraged by the focussed way in which the ECS and oil and gas businesses are responding to cost management initiatives.

"We expect the strong performance by the industrial, medical and other non-oil businesses within AEP to continue for the remainder of the year and we anticipate that, for AEP as a whole, the outcome for the year will be in line with previous management expectations.

"However the recent developments in ECS's businesses will result in full year Group earnings, after recognising a lower tax rate, being slightly below previous management expectations.

"Cash exceptional costs in the current financial year arising from our programme to restructure and refocus our business are expected to remain in line with previous guidance at below £10m."

Jefferies International reiterates buy on Fenner, target cut from 235p to 220p.

Time to dust off the slide rule here?

220 would be nice.

I have a very small quantity I bought at 195 and it hasn't been my best trade.

Yes, I have been tempted, but looking at the 10 year chart and bearing in mind that summer trading is usually very thin, I think there might be a bit more downside. However, on my watchlist.

StockMarketWire.com
Fenner expects group revenue and underlying profit for the year ended 31 August to be in line with forecasts at the time of the trading update on 22 July.

Net debt at 31 August was approximately £140 million, principally reflecting a better than anticipated outcome in respect of working capital.

The group expects to release its results for the full year on 11 November 2015.

Investec Sell 170.50 155.00 140.00 Reiterates

Liberum Capital Hold 170.50 - 200.00 Reiterates

finnCap Hold 170.50 175.00 175.00 Reiterates

Big volume day today which may suggest the worst is over.

RWC European Focus Fund (1), RWC Specialist UK Focus Fund (2) From above 3% to above 4%

Annual revenues fall 9% at Fenner

StockMarketWire.com

Fenner, a leader in reinforced polymer technology, has announced that Group revenue decreased by 9% to £666.7m in the year to August 31 2015 (2014: £729.4m).

Underlying operating profit decreased by 29% to £56.4m (2014: £79.5m).

The company says that throughout the year, there was stringent management of the cost base and several cost restructuring initiatives were completed.

Exceptional items amounted to a charge of £34.4m (2014: £19.7m). This comprised impairment costs relating to goodwill and intangible assets acquired of £24.5m and restructuring costs of £9.9m.

Overall this led to a loss before tax of £5.3m, compared to a profit of £29.2m in the previous year. Nicholas Hobson, chief executive officer, commented: "In the financial year to 31 August 2015, the Group has faced difficult trading conditions in some of its key markets. We have responded by rigorous control of costs and the close management of cash and working capital, whilst still maintaining our ability to resume growth when market conditions allow.

"Trading in the majority of the Group remains in line with management expectations. However, in the light of the recent further deterioration in the US coal industry, the Board envisages that the Group is likely to achieve an outcome for the current financial year which is moderately below its previous expectations."